China SXT Pharmaceuticals annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
China SXT Pharmaceuticals Revenue Growth & History (SXTC)
China SXT Pharmaceuticals reported $1.1M in revenue for fiscal 2026, a decrease of 34.63% from the previous fiscal year.
View full China SXT Pharmaceuticals company overviewChina SXT Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $1.1M | −$602,855 | −34.63% |
| 2025 | 2025-03-31 | $1.7M | −$187,590 | −9.73% |
| 2024 | 2024-03-31 | $1.9M | −$43,182 | −2.19% |
| 2023 | 2023-03-31 | $2.0M | −$630,602 | −24.23% |
| 2022 | 2022-03-31 | $2.6M | −$2.2M | −45.53% |
| 2021 | 2021-03-31 | $4.8M | −$384,695 | −7.45% |
| 2020 | 2020-03-31 | $5.2M | −$1.8M | −26.38% |
| 2019 | 2019-03-31 | $7.0M | −$7,217 | −0.10% |
| 2018 | 2018-03-31 | $7.0M | $2.1M | +43.79% |
| 2017 | 2017-03-31 | $4.9M | — | — |
China SXT Pharmaceuticals revenue growth trends
Over the last five reported fiscal years, revenue declined from $4.8M to $1.1M, a compound annual decline of 24.94%.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review China SXT Pharmaceuticals source filings ↗